Integra LifeSciences Holdings (IART)

Total asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	1,486,381	1,488,778	1,493,656	1,509,844	1,505,291	1,519,581	1,519,648	1,510,233	1,535,982	1,529,270	1,504,267	1,371,086	1,317,264	1,323,744	1,339,441	1,466,719	1,476,695	1,464,883	1,451,126	1,428,751
Total assets	US$ in thousands	3,781,990	3,739,370	3,777,600	3,742,400	3,889,760	3,807,010	3,752,860	3,672,000	3,782,380	3,774,460	3,712,790	3,741,550	3,615,140	3,453,520	3,391,760	3,447,560	3,303,240	3,346,580	3,290,410	3,205,710
Total asset turnover		0.39	0.40	0.40	0.40	0.39	0.40	0.40	0.41	0.41	0.41	0.41	0.37	0.36	0.38	0.39	0.43	0.45	0.44	0.44	0.45

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $1,486,381K ÷ $3,781,990K
= 0.39

The total asset turnover ratio for Integra Lifesciences Holdings Corp has been relatively stable over the past eight quarters, ranging between 0.40 and 0.42. This ratio indicates that, on average, the company generates $0.41 in revenue for every $1 of total assets. A consistent total asset turnover suggests that the company is efficiently utilizing its assets to generate sales. However, further analysis may be needed to understand the factors influencing this metric over time and to assess the overall efficiency of the company's asset management.